These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8927587)

  • 1. [Conditions and consequences of cardiac alterations in patients with end-stage renal disease on maintenance hemodialysis].
    Zabicka H
    Postepy Hig Med Dosw; 1996; 50(3):277-91. PubMed ID: 8927587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular complications in end-stage renal disease and hemodialysis patients.
    Kes P; Drusko D; Rupcić V
    Acta Med Croatica; 1996; 50(4-5):199-208. PubMed ID: 9046118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [So-called uremic heart diseases].
    Grollier G; Hurault de Ligny B; Bonnet H; Scanu P; Potier JC
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):401-6. PubMed ID: 2108635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in patients with chronic kidney disease.
    Lisowska A; Musiał WJ
    Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac disease in patients with end-stage renal disease.
    Staffeld CG; Pastan SO
    Cardiol Clin; 1995 May; 13(2):209-23. PubMed ID: 7614511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmias in hemodialysis patients.
    Voroneanu L; Covic A
    J Nephrol; 2009; 22(6):716-25. PubMed ID: 19967650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac consequences of hypertension in hemodialysis patients.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F
    Semin Dial; 2004; 17(4):299-303. PubMed ID: 15250922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological adequacy--what does it mean?].
    Kes P; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2004; 58(1):1-4. PubMed ID: 15125386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparison of selected parameters of structure and function of the cardiovascular system in patients with functioning graft on maintenance hemodialysis during a one year period].
    Króliczak M; Stompór T; Sułowicz W; Ochmański W; Królczyk J
    Przegl Lek; 2001; 58(10):894-902. PubMed ID: 11957815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diastolic dysfunction in chronic renal failure patients under hemodialysis].
    Douchet MP; Couppie P; Chantrel F; Kuntz C; Hannedouche T
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):589-92. PubMed ID: 9033698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hypertension on cardiovascular outcomes in hemodialysis patients.
    Birchem JA; Fraley MA; Senkottaiyan N; Alpert MA
    Semin Dial; 2005; 18(5):391-5. PubMed ID: 16191179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of arterial compliance in patients treated by hemodialysis.
    Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
    Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective.
    Abassi Z; Nakhoul F; Khankin E; Reisner SA; Yigla M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):353-60. PubMed ID: 16775448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart in end-stage renal failure: etiology, symptoms and management of uremic heart disease.
    Contrib Nephrol; 1986; 52():1-149. PubMed ID: 3568665
    [No Abstract]   [Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.
    Puskar D; Pasini J; Savić I; Bedalov G; Sonicki Z
    Croat Med J; 2002 Jun; 43(3):306-11. PubMed ID: 12035137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.